"Actually, they'll "lend their names out to ANYONE"
It's really not even a matter of "lending their names" - as that is not the business they're in. They are an investment bank and buy the shares in the secondary FOR A DISCOUNT and then turn around and sell them. In turn, the company, OCAT, gets cash for their shares in a single lump sum, the underwriters makes the "spread" on the share discount, plus fees, plus expenses. That's the "deal" in a nut shell. It's not complicated. Underwriters are about making MONEY, LOTS OF MONEY. PERIOD.
They don't care a wit about the company they underwrite- other than, can they sell and flip the deal for a large enough profit for the amount of risk they take. That is their business model. PERIOD.
They are middle-man, money lenders and sales houses. End of story. All they want to know, if they buy OCAT shares, is can they unload them at enough of a profit to meet their internal guidelines and profit targets.
That is why on a riskier, cash poor, tainted past, no cash flow, no earnings OTC stock like OCAT, they, the underwriters, demand a steeper share discount and larger up-front fees and expenses. HIGHER RISK = HIGHER COSTS from the underwriter.
They're not "lending their name" to anything. They buy the shares, sell the deal, flip um as fast as they can, make a market in the stock, short it or whatever, make their money and move on. It's not a love affair; it's just cold, hard, brutal, pure for profit business as done on Wall Street.
AI
